Surveillance of adverse events following immunization of 13-valent pneumococcal conjugate vaccine among infants, in Zhejiang province, China

Surveillance of adverse events following immunization of 13-valent pneumococcal conjugate vaccine among infants, in Zhejiang province, China

Objectives To evaluate the safety of 13-valent pneumococcal conjugate vaccine (PCV13) after its licensure. Methods Review and describe the AEFI reported to national adverse event following immunization surveillance system (NAEFISS) in Zhejiang province from 2017 to 2020. Reporting rates of AEFI were...

Full description

Bibliographic Details
Main Authors: Yu Hu, Xuejiao Pan, Fuxing Chen, Ying Wang, Hui Liang, Linzhi Shen, Yaping Chen, Huakun Lv
Format: Article
Language:English
Published: Taylor & Francis Group 2022-01-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
aefi (adverse events following immunization)
pcv13(13-valent pneumococcal conjugate vaccine)
surveillance
vaccination
safety
infant
Online Access:http://dx.doi.org/10.1080/21645515.2022.2035141

Similar Items

Similar Items